Rudra Prasad Dutta^1*, Heng-Huan Lee, Ph.D^2*, Ravi Prakash Shukla, Ph.D^1*, Violetta V Leshchenko, Ph.D^1*, Fanye Meng, Ph.D^3*, Fangfang Yan, Ph.D^2*, Yang Liu, Ph.D^2*, Husnu Kaniskan, Ph.D^3*, Jian Jin, Ph.D^3*, Lapo Alinari, MD, Ph.D⁴, Michael Wang, MD² and Samir Parekh, MD¹

¹Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, Mount Sinai Center for Therapeutics Discovery, Tisch Cancer Institute, New York, NY
⁴Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH

Betsy A Pray, MSc, DVM, BS¹, Ethan Baiocchi^2*, Sydney Leon^2*, Brian Barta^2*, Shirsha Koirala^2*, Wing Chan, PhD², Walter Hanel, MD, PhD³, Lalit Sehgal, PhD², Robert Baiocchi, MD, PhD² and Lapo Alinari, MD, Ph.D²

¹College of Veterinary Medicine, The Ohio State University, WESTERVILLE, OH
²James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
³James Comprehensive Cancer Center, The Ohio State University, Dublin, OH

Dengchao Cao, PhD^1*, Mianmian Yin, PhD^1*, Timour Baslan, PhD^2*, Ryan Bertoli, BS^1*, Zhenhua Zhang, MS^1*, Yuelin Zhu, PhD^1*, Paul S. Meltzer, MD, PhD^1* and Peter D. Aplan, MD¹

¹Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY

Aki Tanabe, MD, PhD^1*, Yoshiaki Takahashi^2*, Anna Yui^3*, Makoto Nakakido^3*, Tomohiro Nasu^4*, Mami Uemura^5*, Kenta Tezuka^5*, Kaoru Uchimaru, MD, PhD^4*, Atae Utsunomiya, MD, PhD⁶, Tetsuro Matano^7*, Takuo Mizukami^5*, Toshiki Watanabe^8*, Kouhei Tsumoto^3,9,10* and Kazumi Nakano^5*

¹AIDS research center, National Institute of Infectious Diseases, Shinjuku, TKY, Japan
²Department of Investigative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan
³Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan
⁴Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
⁵Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan
⁶Department of Hematology, Imamura General Hospital, Kagoshima, Japan
⁷AIDS research center, National Institute of Infectious Diseases, Tokyo, Japan
⁸Department of Hematology/Oncology, St. Marianna University School of Medicine, Kanagawa, Japan
⁹Department of chemistry and Biotechnology, School of Engineering, The University of Tokyo, Tokyo, Japan
¹⁰The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Samuel J. Holzmayer^1,2*, Jonas Mauermann^1,2*, Sarah M. Greiner^1,2,3*, Jonas S. Heitmann, MD^1,2*, Kübra Kaban^1,2*, Helmut R. Salih, MD^1,2* and Melanie Maerklin^1,2*

¹DFG Cluster of Excellence 2180 ‘Image-guided and Functional Instructed Tumor Therapy’ (IFIT), University of Tübingen, Tübingen, Germany
²Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany
³Department of Obstetrics and Gynecology, University Hospital Tübingen, Tübingen, Germany

Peter Gordon, MD/PhD^1,2,3, Robin Williams, MD, MS⁴, Jason Ostergaard, BS^5*, Joseph Muretta, PhD^6*, Bridget S. Wilson, PhD^7*, Luke Lambert, MS^8*, Timothy P. Singleton, MD⁹, Sarah K Tasian, MD¹⁰ and Stuart S. Winter, MD^11,12

¹Pediatric Hematology/Oncology, Umn Center For Allied Health Programs, Saint Paul, MN
²Masonic Cancer Center, University of Minnesota, Minneapolis, MN
³Umn Center For Allied Health Programs, Minneapolis, MN
⁴University of Minnesota Masonic Children’s Hospital, Saint Paul, MN
⁵Pediatric Hematology/Oncology, University of Minnesota, Minneapolis, MN
⁶College of Biological Sciences, University of Minnesota, Minneapolis, MN
⁷Pathology, University of New Mexico, Albuquerque, NM
⁸Children's Minnesota, Minnesota, MN
⁹Children's Minnesota, Edina, MN
¹⁰Division of Oncology & Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
¹¹Cancer and Blood Disorders, Children's Minnesota, Eagan, MN
¹²Cancer and Blood Disorders, Children's Minnesota, Minneapolis, MN

Lorena Fontan, PhD¹, Adam Zwolak^2*, Irene Guimerans-Lorenzo^1*, Mariette Bekkers^1*, Nicholas Hein^2*, Nele Vloemans^1*, Emanuele Trella^1*, Tina Smets^1*, Ivo Cornelissen^1*, Alemu Assefa^1*, Bie Verbist, PhD^1*, Ricardo Amorim, PhD^1*, Pankaj Seth, PhD^2*, Ranjeet Prasad Dash^2*, Leopoldo Luistro, PhD^2*, Bethany Mattson, PhD^2*, Matthew A. Dragovich^3*, Michael Hedvat^3*, Gregory L. Moore^3*, John R. Desjarlais, PhD^3*, Olivia Kutlu^4*, Joseph Erhardt^2* and Ulrike Philippar, PhD¹

¹Janssen Research & Development, Beerse, Belgium
²Janssen Research & Development, Spring House, PA
³Xencor, Inc., Pasadena, CA
⁴Janssen Research & Development, Los Angeles, CA

Junfei Zhao^1*, Marta Larrayoz, PhD^2*, Chad C. Bjorklund^1*, Anita K. Gandhi, PhD³, Jose A. Martinez-Climent, MD, PhD⁴, Patrick R. Hagner, PhD^1* and Maria Ortiz^5*

¹Bristol Myers Squibb, Summit, NJ
²Hematology and Oncology Program, Centre for Applied Medical Research (CIMA), Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain
³Translational Medicine, Bristol Myers Squibb, Summit, NJ
⁴Department of Hematology, Centre for Applied Medical Research, Cancer Center Clinica Universidad de Navarra, University of Navarra, IdiSNA, CIBERONC, Pamplona, Spain
⁵Bristol Myers Squibb, Seville, Spain

Shiyi Xie^1*, Zhen Yu^2,3*, Mu Hao, MD^3*, Lu-Gui Qiu³, Mariateresa Fulciniti, PhD⁴, Nikhil C. Munshi, MD⁵ and Yan Xu, MD^6,7*

¹Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Tianjin, China
²State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, CHN
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁴Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁵Dana-Farber Cancer Institute, Boston, MA
⁶Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
⁷State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Boston, MA

Daisy V. Tran^1*, Evelyn Teh, PhD^2*, Susanne Penny, PhD^2*, Devanand M. Pinto, PhD^2*, Samuel D. Saibil, MD, PhD^1*, John Kuruvilla, MD, FRCPC¹ and Rob C. Laister, PhD¹

¹Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
²Human Health Therapeutics, National Research Council, Halifax, NS, Canada

Kadriye Nehir Cosgun, PhD^1*, Mark E Robinson, PhD^1*, Nikol Agadzhanian, MSc^1*, Philipp Berning, MD^1*, David Fonseca-Arce^1*, Etienne Leveille, MD^1*, Shalin Kothari, MD^1*, Matthew S. Davids, MD, MMSc², Julia Jellusova, PhD^3* and Markus Müschen, MD¹

¹Center of Molecular and Cellular Oncology, Yale University, New Haven, CT
²Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA
³School of Medicine and Health, TranslaTUM, Institute of Clinical Chemistry and Pathobiochemistry, Munich, Germany

Caiqin Wang^1*, Yizi He^1*, Yajun Li, MD^2*, Ruolan Zeng^1*, Zhiming Li, PhD, MD³, Ling Xiao^4* and Hui Zhou, PhD¹

¹Department of Lymphoma and Hematology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China
²Hunan Cancer Hospital, Changsha, China
³Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
⁴Department of Histology and Embryology of School of Basic Medical Science, Central South University, Changsha, China

Mahipal Gurram Sinnollareddy, PhD^1*, Leonid Gibiansky, PhD^2*, Kinjal Sanghavi, PhD^3*, Steven Xu, PhD^4*, Mohamed-Eslam F Mohamed, PhD^1*, Poliana P. Patah¹, Elena Favaro, MD, PhD^5*, Manish Gupta, PhD^4*, Apurvasena Parikh, PhD^6* and Tommy Li, PhD^4*

¹AbbVie, North Chicago, IL
²QuantPharm LLC, North Potomac, MD
³Genmab, Plainsboro, NJ
⁴Genmab, Princeton, NJ
⁵Genmab, Copenhagen, Denmark
⁶AbbVie Inc., South San Francisco, CA

Zhiyan Liang, PhD^1*, Yan Yin, MS^2*, Huanshan Guo, MD^3*, Baisong Li, MS^2*, Dajun Yang, MD, PhD^1,2,4* and Yifan Zhai, MD, PhD^1,2,3

¹Ascentage Pharma Group Inc., Rockville, MD
²Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China
³Guangzhou Healthquest Pharma Co., Ltd., Guangzhou, China
⁴Department of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China

Edward Chow^1*, Rui Xue Lee^2*, Jhin Jieh Lim^1* and Masturah Rashid^1*

¹KYAN Technologies, Singapore, Singapore
²National University of Singapore, Singapore, Singapore

Calvin Lam¹, Yiqian Wang, BS^2*, Victor Rivero^1*, Jogdeo Chinmay, PhD^3*, Ekta Kapoor, PhD^3*, Siyuan Tang, PhD^3*, Peng Xiao, PhD^4*, Svetlana Romanova, PhD^3*, David Oupicky, PhD^3* and Kate Hyde, PhD^5,6

¹Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE
²University of Nebraska Medical Center, Omaha, NE
³Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE
⁴Department of Genetics, Cell Biology, and Anatomy, and UNMC Bioinformatics and Systems Biology Core, University of Nebraska Medical Center, Omaha, NE
⁵Department of Biochemistry and Molecular Biology, and Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE
⁶NIH, Bethesda, MD

Samantha Hurwitz, PhD¹, Tatiana Fourfouris, MSc¹, Rachel Friedmann, DO^1*, Ki Jun Lee, MSc¹, Zesheng Wan, PhD^1*, Sarah Richmann, MD PhD^2*, Babak Moghimi, MD^3*, Fariba Navid, MD^4*, Justine Delgado, PhD^5*, Chintan Parekh, MD⁶, Deepa Bhojwani, MD⁷ and Yong-Mi Kim, MD, PhD, MPH¹

¹Children's Hospital of Los Angeles, University of Southern California, Los Angeles, CA
²Children's Hospital Los Angeles, University of Southern California, Los Angeles
³Children’s Hospital Los Angeles, Los Angeles, CA
⁴Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA
⁵Iterion Therapeutics, Houston
⁶City of Hope, Beckman Research Institute, Duarte
⁷Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, CA

Donia M. Moujalled, PhD^1,2*, Seong Lin Khaw, MBBS, PhD, FRACP^2,3,4, Teresa Sadras, PhD^5*, Giovanna Pomilio^1,2*, Thomas Morley^1,2*, Veronique Litalien^1,2*, Louise Ludlow, PhD^6*, Paul G. Ekert, MBBS, PhD, FRACP^5,7 and Diane Hanna, MD PhD^2,3,8

¹The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
²Department of Medical Biology, The University of Melbourne, Melbourne, Australia
³Murdoch Children’s Research Institute, Melbourne, VIC, Australia
⁴Royal Children's Hospital, Melbourne, Australia
⁵Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
⁶Royal Children’s Hospital, Melbourne, Australia
⁷Children’s Cancer Institute, Sydney, Australia
⁸Children's Cancer Centre, The Royal Children's Hospital Melbourne, Parkville, VIC, Australia